Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Report ID | 253444 |
Drug Identification Number | 02408813 |
Brand name | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE |
Common or Proper name | CISATRACURIUM BESYLATE INJECTION |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CISATRACURIUM |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 x 10ML VIAL / FIOLE |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2025-03-26 |
Estimated end date | 2025-04-15 |
Actual end date | 2025-04-14 |
Shortage status | Resolved |
Updated date | 2025-04-15 |
Company comments | Product remains available at CPDN. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2025-04-15 | English | Compare |
v5 | 2025-04-08 | French | Compare |
v4 | 2025-04-08 | English | Compare |
v3 | 2025-03-27 | English | Compare |
v2 | 2025-03-26 | French | Compare |
v1 | 2025-03-26 | English | Compare |
Showing 1 to 6 of 6